Department of Obstetrics & Gynecology, Massachusetts General Hospital, Vincent Center for Reproductive Biology, Massachusetts General Hospital Research Institute, USA.
Department of Obstetrics & Gynecology, Massachusetts General Hospital, Vincent Center for Reproductive Biology, Massachusetts General Hospital Research Institute, USA.
Microb Pathog. 2020 Nov;148:104544. doi: 10.1016/j.micpath.2020.104544. Epub 2020 Oct 1.
Urinary tract infections (UTIs) are one of the most common infections in women. The only proven preventive strategy for recurrent UTIs is prophylactic antibiotics. Given growing antibiotic resistance, the use of probiotics has been proposed as an alternative to antibiotics. Herein, we discuss the current evidence to support the possibility that exogenous lactobacilli may limit the pathogenicity of uropathogens such as E. coli. Probiotics appear to have a significant potential in prevention of recurrent UTI, however, additional data are needed to understand how they can be effectively used in clinical practice.
尿路感染(UTIs)是女性最常见的感染之一。唯一被证实可预防复发性尿路感染的策略是预防性使用抗生素。鉴于抗生素耐药性日益增加,益生菌的使用已被提议作为抗生素的替代品。本文讨论了目前的证据,以支持外源性乳杆菌可能限制大肠杆菌等尿路病原体致病性的可能性。益生菌在预防复发性尿路感染方面似乎具有很大的潜力,但是需要更多的数据来了解如何在临床实践中有效地使用它们。